BlackRock Fund Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$36.2M	Buy	2,270,297 +679,195	+43%	+$10.9M	0.01%	1873
2016 Q3	$26.5M	Buy	1,591,102 +74,095	+5%	+$998K	0.01%	1934
2016 Q2	$17M	Sell	1,517,007 -125,063	-8%	-$1.21M	﹤0.01%	2116
2016 Q1	$13.7M	Buy	1,642,070 +19,224	+1%	+$158K	﹤0.01%	2193
2015 Q4	$15.1M	Sell	1,622,846 -61,938	-4%	-$618K	﹤0.01%	2199
2015 Q3	$19M	Buy	1,684,784 +43,073	+3%	+$527K	﹤0.01%	2017
2015 Q2	$20.8M	Buy	1,641,711 +156,520	+11%	+$1.69M	0.01%	2093
2015 Q1	$13.8M	Sell	1,485,191 -68,098	-4%	-$769K	﹤0.01%	2269
2014 Q4	$22.2M	Buy	1,553,289 +323,759	+26%	+$3.83M	0.01%	2005
2014 Q3	$12.8M	Sell	1,229,530 -14,813	-1%	-$194K	﹤0.01%	2215
2014 Q2	$20.1M	Sell	1,244,343 -91,696	-7%	-$1.22M	0.01%	2018
2014 Q1	$21.7M	Buy	1,336,039 +56,958	+4%	+$810K	0.01%	1955
2013 Q4	$15.9M	Sell	1,279,081 -21,050	-2%	-$211K	﹤0.01%	2113
2013 Q3	$14.2M	Buy	1,300,131 +331,630	+34%	+$3.54M	﹤0.01%	2150
2013 Q2	$7.83M	Buy	+968,501	New	+$6.52M	﹤0.01%	2413